Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON21978
NL-OMON21978CompletedNot Applicable

Elucidating the therapeutic mechanism of DBS by simultaneously stimulating and recording from the target brain region.

Board of Directors, Academic Medical Center, Amsterdam0 sites11 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
11
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Subject has provided informed consent.
  • •Primary diagnosis of OCD with DBS-implantation performed in the AMC in the previous years.
  • •Primary diagnosis of OCD and indicated for DBS-implantation in the AMC.
  • •DBS-treatment responsiveness, defined as an improvement in Y-BOCS of >35% at last follow-up compared to pre-surgical baseline.

Exclusion Criteria

  • •Subject is unwilling or unable to comply with all study-required follow-up evaluations.
  • •Alcohol or substance abuse during last 6 months.

Investigators

Sponsor
Board of Directors, Academic Medical Center, Amsterdam

Similar Trials

Recruiting
Phase 1
Study on the Therapeutic Effect and Mechanism of Bushen Yisui Capsules Against Multiple Sclerosis with Depression Based on Multi-modality Analysismultiple sclerosis
ITMCTR2000003158Beijing Tiantan Hospital, Capital Medical University
Recruiting
Phase 2
Evaluation of Usefulness of BP for DSODiffuse Sclerosing Osteomyelitis of the jawDSO
JPRN-jRCTs011180002Kitagawa Yoshimasa13
Recruiting
Not Applicable
Delivering radiation therapy to chest lymphomas(cancer) in deep inspiration.
CTRI/2018/07/014847Tata Memorial Center
Active, not recruiting
Phase 1
A study testing how BI 655130 works in patients with fistulizing Crohn’s DiseaseFistulizing Crohn’s DiseaseMedDRA version: 20.0Level: LLTClassification code 10075465Term: Fistulizing Crohn's diseaseSystem Organ Class: 100000004856
EUCTR2017-003090-34-NLBoehringer Ingelheim Netherlands BV28
Active, not recruiting
Phase 1
A study testing how BI 655130 works in patients with fistulizing Crohn’s DiseaseFistulizing Crohn’s DiseaseMedDRA version: 20.0 Level: LLT Classification code 10075465 Term: Fistulizing Crohn's disease System Organ Class: 100000004856
EUCTR2017-003090-34-HUBoehringer Ingelheim RCV GmbH & Co KG28